5 Year History

FIVE YEAR STATEMENT

 

2017

£’m

2016

£’m

2015

£’m

2014

£’m

2013

£’m

Turnover^

1,245.1

1,016.3

1,003.3

994.9

875.2

Profit before tax^

77.5

62.1

52.8

54.8

47.3

Adjusted profit before tax*^

75.5

64.4

57.8

52.2

49.1

Earnings per share^

124.2p

98.9p

84.1p

88.7p

74.9p

Adjusted earnings per share*^

120.9p

102.8p

92.1p

84.1p

78.7p

Dividends per share

44.1p

37.5p

34.0p

32.0p

30.0p

Capital expenditure

48.6

34.1

23.3

22.9

33.2

Net (debt)/funds

(11.0)

17.8

(17.3)

(17.0)

(20.1)

Net assets

421.4

368.0

332.4

302.7

273.7

 

*    Adjusted profit before tax and earnings per share exclude the effects of net IAS 41 valuation movement and acquisition related amortisation in 2017; the effects of net IAS 41 valuation movement, acquisition related amortisation and impairment of goodwill in 2016; net IAS 41 valuation movement and acquisition related amortisation in 2015; release of contingent consideration and net IAS 41 valuation movement on biological assets in 2014 and impairment of property, plant and equipment in 2013. These are the measures used by the Board to assess the Group’s underlying performance.

^    2017 and 2016 reflect continuing operations only.

Dividends per share relate to dividends declared in respect of that year.